American Thoracic Society (ATS)

Founded in 1905, the American Thoracic Society is the world’s leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s nearly 17,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes four journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the Annals of the American Thoracic Society and ATS Scholar.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care have gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations.

Among the specialties represented in sessions at the international conference are allergy/immunology, bronchiectasis, COPD, cellular/molecular biology, critical care, idiopathic pulmonary fibrosis, interstitial lung disease, pediatrics, and sleep. More than 5,000 attendees from countries outside the U.S. attended the conference in 2019.

ATS 2022 Respiratory Innovation Summit will unite the innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways.

For 2022, the focus areas are fibrosis, inflammation, and COVID-19. Each area will feature an expert panel discussion and five innovating companies in focused, interactive burst sessions. The agenda also includes a CEO panel, business development panel, and plenty of time for networking among posters from innovative companies.  ATS 2022 Summit